Predicting outcome in severe heart failure. Who will benefit from device therapy (CRT)?

European Heart Journal

Volumn 28, Issue 15, 2007, Pages 1790-1792

  Doughty, Robert Neil ^a,b   Poppe, Katrina ^a   Stewart, James ^b  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b AUCKLAND CITY HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

BUNDLE-BRANCH BLOCK; CARDIAC PACING, ARTIFICIAL; ELECTROCARDIOGRAPHY; HEART FAILURE; HUMANS; PROGNOSIS; SEVERITY OF ILLNESS INDEX; SICKNESS IMPACT PROFILE; TREATMENT OUTCOME;

EID: 34547725717     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehm254     Document Type: Editorial

References (15)

1. Cazeau S, Ritter P, Bakdach S et al. Four chamber pacing in dilated cardiomyopathy. PACE 1994;17:1974-1979.
2. Wilensky RL, Yudelman P, Cohen AI. Serial electrocardiographic changes in idiopathic dilated cardiomyopathy confirmed at necropsy. Am J Cardiol 1988;62:276-283.
3. Shamim W, Francis DP, Yousufuddin M et al. Intraventricular conduction delay: a prognostic marker in chronic heart failure. Int J Cardiol 1999; 70:171-178.
4. Xiao HB, Roy C, Fujimoto S, Gibson DG. Natural history of abnormal conduction and its relation to prognosis in patients with dilated cardiomyopathy. Int J Cardiol 1996;53:163-170.
5. Abraham WT, Fisher WG, Smith AL et al. for the MIRACLE Study Group. Cardiac resynchronisation in chronic heart failure. N Engl J Med 2002; 346:1845-1853.
6. Bristow MR, Saxon LA, Boehmer J et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140-2150.
7. Cazeau S, Leclercq C, Lavergne T et al. for the Multisite Stimulation in Cardiomyopathies (MUSTIC) Study Investigators. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001;344:873-880.
8. Leclercq C, Kass DA. Retiming the failing heart: principles and current clinical status of cardiac resynchronisation. J Am Coll Cardiol 2002;39: 194-201.
9. Cleland JGF, Daubert J-C, Erdmann E et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352:1539-1549.
10. Swedberg K, Writing C et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): the Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 2005;26:1115-1140.
11. Abraham WT. Cardiac resynchronisation therapy: a review of clinical trials and criteria for identifying the appropriate patient. Rev Cardiovasc Med 2003;4:S30-S37.
12. Reuter S, Garrigue S, Barold SS et al. Comparison of characteristics in responders versus non-responders with biventricular pacing for drug resistant heart failure. Am J Cardiol 2002;89:346-350.
13. Tournoux FB, Alabiad C, Fan D et al. Echocardiographic measures of acute haemodynamic response after cardiac resynchronisation therapy predict long-term clinical outcome. Eur Heart J 2007;28:1143-1148.
14. Yu C-M, Bleeker GB, Fung JW-H et al. Left ventricular reverse remodeling but not clinical improvement predicts long-term survival after cardiac resynchronization therapy. Circulation 2005;112:1580-1586.
15. Richardson M, Freemantle N, Calvert MJ, Cleland JGF, Tavazzi L. Predictors and treatment response with cardiac resynchronization therapy in patients with heart failure characterized by dyssynchrony: a predefined analysis from the CARE-HF trial. Eur Heart J 2007; 28:1827-1834. First published on May 31, 2007, doi:10.1093/eurheartj/ehm192.